Skip to content
10-Q

Quarterly Report

Orion Biotech Opportunities Corp.

0001213900-22-025311

← back to feed
Filed
May 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$136.57K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $575.9K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $712.47K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$9.14M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$13.76M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$20.09K
Current Liabilities Q1 2022 · Mar 31, 2022 $110.04K
Current Liabilities Q1 2022 · Dec 31, 2021 $81.63K
Total Liabilities Q1 2022 · Mar 31, 2022 $10.26M
Total Liabilities Q1 2022 · Dec 31, 2021 $15.12M
Current Assets Q1 2022 · Mar 31, 2022 $1.1M
Current Assets Q1 2022 · Dec 31, 2021 $1.35M
Total Assets Q1 2022 · Mar 31, 2022 $201.12M
Total Assets Q1 2022 · Dec 31, 2021 $201.36M
Sga Expense Q1 2022 · Mar 31, 2022 $256.16K
Sga Expense Q1 2022 · Mar 31, 2021 $45.09K
Net Income Q1 2022 · Mar 31, 2022 $4.62M
Net Income Q1 2022 · Mar 31, 2021 −$45.09K
Operating Income Q1 2022 · Mar 31, 2022 −$286.16K
Operating Income Q1 2022 · Mar 31, 2021 $45.09K